R
R. Nagarajan
Researcher at Indian Institute of Technology Madras
Publications - 9
Citations - 116
R. Nagarajan is an academic researcher from Indian Institute of Technology Madras. The author has contributed to research in topics: Cancer & Engineering. The author has an hindex of 3, co-authored 4 publications receiving 57 citations.
Papers
More filters
Journal ArticleDOI
Anticancer and antibacterial effects of a clove bud essential oil-based nanoscale emulsion system.
TL;DR: The clove bud-based nanoscale emulsion is positioned as a suitable candidate for further in vivo studies and trials as a cancer drug.
Journal ArticleDOI
Synergistic effect of mixed anionic and cationic surfactant systems on the interfacial tension of crude oil-water and enhanced oil recovery
TL;DR: In this paper, individual and mixed systems of anionic and cationic surfacta were used for enhanced oil recovery (EOR) using anionic surfactants and anionic acid.
Journal ArticleDOI
Investigations on the thermal and electrical conductivity of polyethylene glycol-based CuO and ZnO nanofluids
Swaminathan Ponmani,Swaminathan Ponmani,Pawan Gupta,Pawan Gupta,Prashant Sopanrao Jadhawar,R. Nagarajan,Jitendra S. Sangwai +6 more
TL;DR: In this article, three different types of nanofluids were evaluated for their stability using dynamic light scattering and particle morphological study using scanning electron microscopy, and the results showed that they were stable in terms of particle morphology.
Journal ArticleDOI
Mechanistic study of ultrasound-assisted solvent leaching of sodium and potassium from an Indian coal using continuous and pulsed modes of operation
H. Srivalli,R. Nagarajan +1 more
TL;DR: In this paper, fly ash particles travel along with flue gas and get deposited on heat transfer surfaces along the way, and Fouling and slagging are generated by fly ash and bottom ash.
Journal ArticleDOI
Cancer nanomedicine: a review of nano-therapeutics and challenges ahead
TL;DR: In this article , the authors highlight the evolution and current status of cancer therapy, with a focus on clinical/pre-clinical nanomedicine cancer studies and highlight the prospects in this regard.